Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Estimating the Population-Based Prevalence of Congenital Thrombotic Thrombocytopenic Purpura Using Large-Scale Sequencing Data

Omid Seidizadeh, Andrea Cairo, Ilaria Mancini, Pasquale Agosti, Frits Rosendaal, Flora Peyvandi

Blood (2023) 142 (Supplement 1): 693.

https://doi.org/10.1182/blood-2023-180560

Published: 2023

Journal Articles

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Frits Rosendaal, MD PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Piermannuccio Mannucci, MD, Flora Peyvandi, MD PhD

Blood (2016) 128 (22): 325.

https://doi.org/10.1182/blood.V128.22.325.325

Published: 2016

Journal Articles

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Flora Peyvandi, MD PhD, Antonino Cannavò, MD, Isabella Garagiola, PhD, Roberta Palla, PhD, Frits Rosendaal, MD PhD, Piermannuccio Mannucci, MD

Blood (2016) 128 (22): 330.

https://doi.org/10.1182/blood.V128.22.330.330

Published: 2016

Journal Articles

Risk of Venous Thromboembolism in Hematological Malignancies: The Scandinavian Thrombosis and Cancer Cohort

Inger Lise Gade, MD, Sigrid K Brækkan, Inger Anne Næss, MD, John-Bjarne Hansen, MD, Frits Rosendaal, MD, Suzanne C Cannegieter, MD, Kim Overvad, MD, Hilde Jensvoll, MD, Jens Hammerstrøm, MD, Kristine Blix, MD, Anne Tjønneland, MD, Søren R Kristensen, MD, Marianne Tang Severinsen

Blood (2015) 126 (23): 628.

https://doi.org/10.1182/blood.V126.23.628.628

Published: 2015

Journal Articles

Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis

Anders E. A. Dahm, PhD, Irene D. Bezemer, PhD, Astrid Bergrem, PhD, Anne Flem Jacobsen, PhD, Eva Marie Jacobsen, PhD, Grethe Skretting, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2010) 116 (21): 4203.

https://doi.org/10.1182/blood.V116.21.4203.4203

Published: 2010

Journal Articles

The Risk of Venous Thrombosis Related to Increase in Body Mass Index Is Mediated by Factor VIII Induced APC-Resistance.

Willem M Lijfering, MD, Sverre C Christiansen, Inger-Anne Naess, Jens Hammerstrøm, Astrid van Hylckama Vlieg, Frits Rosendaal, MD, PhD, Suzanne C Cannegieter

Blood (2009) 114 (22): 453.

https://doi.org/10.1182/blood.V114.22.453.453

Published: 2009

Journal Articles

Copy Number Variation of PROS1 and Protein S Deficiency Are Rare in a Population-Based Case-Control Study On Venous Thrombosis (MEGA study).

Maria Carolina Pintao, MD, Irene D Bezemer, M.S., Andrea Aparecida Garcia, MD, PhD, Marieke C.H. de Visser, MD, PhD, Carine J.M. Doggen, Pieter H. Reitsma, PhD, Frits Rosendaal, MD, PhD

Blood (2009) 114 (22): 3166.

https://doi.org/10.1182/blood.V114.22.3166.3166

Published: 2009

Journal Articles

A Replication Study of Gene Variants Associated with Venous Thrombosis. Results From a Population-Based Nested Case-Cohort Study.

Willem M Lijfering, MD, Irene D Bezemer, M.S., Sverre C Christiansen, Inger-Anne Naess, Frits Rosendaal, MD, PhD, Jens Hammerstrøm, Suzanne C Cannegieter

Blood (2009) 114 (22): 3985.

https://doi.org/10.1182/blood.V114.22.3985.3985

Published: 2009

Journal Articles

Decreased beta2-Glycoprotein I Plasma Levels as a Risk Factor for Myocardial Infarction in Men.

Bas De Laat, PhD, Philip G. de Groot, PhD, Ronald H.W.M. Derksen, MD., Rolf T. Urbanus, Koen Mertens, PhD, Frits Rosendaal, MD, PhD, Carine J.M. Doggen, PhD

Blood (2008) 112 (11): 1813.

https://doi.org/10.1182/blood.V112.11.1813.1813

Published: 2008

Journal Articles

IGSF4: A Novel Candidate Gene for Venous Thrombosis

Edwin Bovill, MD, Irene D Bezemer, M.S., Sandra J Hasstedt, Ph.D, Peter W Callas, Ph.D., Robert P. Hebbel, MD, Frits Rosendaal, MD, PhD

Blood (2008) 112 (11): 405.

https://doi.org/10.1182/blood.V112.11.405.405

Published: 2008

Journal Articles

Heritability of Inter-Related Clotting Factors.

Carla Vossen, MS, Peter Callas, PhD, Frits Rosendaal, PhD, MD, Sandra Hasstedt, PhD, Bruce Scott, PhD, George Long, PhD, Edwin Bovill, MD

Blood (2004) 104 (11): 2585.

https://doi.org/10.1182/blood.V104.11.2585.2585

Published: 2004

Journal Articles

Biological Relevance of a New TFPI Anticoagulant Activity Assay of Full-Length TFPI.

Anders E.A. Dahm, MD, Trine O. Andersen, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2004) 104 (11): 2982.

https://doi.org/10.1182/blood.V104.11.2982.2982

Published: 2004

Journal Articles

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

Gerard M.J. Bos, MD, PhD, Martin Heijer den, MD, PhD, Huub Willems, MD, Henk Blom, PhD, Wim Gerrits, MD, Marco Cattaneo, MD, Sabine Eichinger, MD, Frits Rosendaal, MD

Blood (2004) 104 (11): 489.

https://doi.org/10.1182/blood.V104.11.489.489

Published: 2004

Journal Articles

A Novel Assay for Tissue Factor Pathway Inhibitor (TFPI) Anticoagulant Activity in Plasma.

Anders E.A. Dahm, MD, Trine O. Andersen, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2004) 104 (11): 3987.

https://doi.org/10.1182/blood.V104.11.3987.3987

Published: 2004

Journal Articles

Evidence on Chromosome 11 for a Quantitative Trait Locus Influencing Levels of Activated Protein C-Protein C Inhibitor Complex.

Carla Vossen, MS, Sandra Hasstedt, PhD, Peter Callas, PhD, Bruce Scott, PhD, George Long, PhD, Frits Rosendaal, PhD, MD, Edwin Bovill, MD

Blood (2004) 104 (11): 3511.

https://doi.org/10.1182/blood.V104.11.3511.3511

Published: 2004

Journal Articles

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

Anders Dahm, Astrid van Hylckama Vlieg, Bjorn Bendz, Frits Rosendaal, Rogier M. Bertina, Per Morten Sandset

Blood (2003) 101 (11): 4387–4392.

https://doi.org/10.1182/blood-2002-10-3188

Published: 2003

NARROW

Estimating the Population-Based Prevalence of Congenital Thrombotic Thrombocytopenic Purpura Using Large-Scale Sequencing Data

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Risk of Venous Thromboembolism in Hematological Malignancies: The Scandinavian Thrombosis and Cancer Cohort

Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis

The Risk of Venous Thrombosis Related to Increase in Body Mass Index Is Mediated by Factor VIII Induced APC-Resistance.

Copy Number Variation of PROS1 and Protein S Deficiency Are Rare in a Population-Based Case-Control Study On Venous Thrombosis (MEGA study).

A Replication Study of Gene Variants Associated with Venous Thrombosis. Results From a Population-Based Nested Case-Cohort Study.

Decreased beta2-Glycoprotein I Plasma Levels as a Risk Factor for Myocardial Infarction in Men.

IGSF4: A Novel Candidate Gene for Venous Thrombosis

Heritability of Inter-Related Clotting Factors.

Biological Relevance of a New TFPI Anticoagulant Activity Assay of Full-Length TFPI.

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

A Novel Assay for Tissue Factor Pathway Inhibitor (TFPI) Anticoagulant Activity in Plasma.

Evidence on Chromosome 11 for a Quantitative Trait Locus Influencing Levels of Activated Protein C-Protein C Inhibitor Complex.

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only